Immunology. Close to the edge: neutralizing the HIV-1 envelope.
Nabel
Gary J
GJ
Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. gnabel@nih.gov
D016915:AIDS Vaccines / Q000627:therapeutic use; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D000918:Antibody Specificity; D001324:Autoantigens / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology; D002308:Cardiolipins / Q000276:immunology*; D022801:Complementarity Determining Regions; D000939:Epitopes; D015686:Gene Products, env / Q000737:chemistry / Q000276:immunology*; D015483:HIV Antibodies / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D015700:HIV Envelope Protein gp41 / Q000737:chemistry / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D007116:Immunization, Passive; D008958:Models, Molecular; D009154:Mutation; D009500:Neutralization Tests; D017434:Protein Structure, Tertiary
D016915:AIDS Vaccines; D000911:Antibodies, Monoclonal; D001324:Autoantigens; D002308:Cardiolipins; D022801:Complementarity Determining Regions; D000939:Epitopes; D015686:Gene Products, env; D015483:HIV Antibodies; D015700:HIV Envelope Protein gp41